Article Information
vol. 30 no. 162
PubMed
Published By
Print ISSN
Online ISSN
History
- Received June 30, 2021
- Accepted September 3, 2021
- Published online December 15, 2021.
Copyright & Usage
Copyright ©The authors 2021 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- 1Pulmonary Division, Lady Davis Carmel Medical Center, Faculty of Medicine Technion Institute of Technology, Haifa, Israel
- 2Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel
- 3Dept of Community Medicine and Epidemiology, Lady Davis Carmel Medical Center, Haifa, Israel
- 4Université Paris-Saclay, Le Kremlin-Bicêtre, France
- 5Dept of Respiratory and Intensive Care Medicine, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Bicêtre, Le Kremlin-Bicêtre, France
- 6INSERM, UMR_S 999, Hôpital Marie Lannelongue, Le Plessis-Robinson, France
- Corresponding author: Yochai Adir (adir-sh{at}zahav.net.il)
Article usage
Altmetrics
Vol 30 Issue 162
Table of Contents
Asthma and COVID-19: an update
Jump To
- Article
- Abstract
- Abstract
- Introduction
- Does asthma increase the risk for SARS-CoV-2 infection?
- Does asthma increase the risk of severe COVID-19?
- Severe asthma and COVID-19
- Asthma phenotype and COVID-19
- Asthma medications and the risk for SARS-CoV-2 infection and disease severity
- ICS
- SCS (figure 2)
- Biologics
- Conclusion
- Footnotes
- References
- Figures & Data
- Info & Metrics